John V. Soden

Managing Director

(415) 962-2922
Download vCard

Cain Brothers Experience

John Soden co-leads Cain Brothers’ Medical Technologies Advisory practice based in San Francisco.  Mr. Soden joined Cain Brothers in 2016 with over 20 years of investment banking experience focused on private and public company M&A.  Recent advisory transactions include the sale of SeraCare Life Sciences (owned by Linden) to LGC (owned by KKR), California Cryobank’s sale to GI Partners and its simultaneous merger with Cord Blood Registry, Patricia Industries’ acquisition of Sarnova from Water Street, 3i Group’s acquisition of Cirtec Medical, Frazier’s merger of PREZIO and Northfield, and the sale of Clinical Innovations by The Pritzker Group to EQT Partners.  Mr. Soden’s transactions immediately prior to joining Cain Brothers included the sales of Hygiena to Warburg Pincus, Galil Medical to BTG Plc, CORPAK MedSystems (owned by Linden) to Halyard Health, Cord Blood Registry (owned by GTCR) to AMAG Pharmaceuticals, Ivera Medical to 3M, Integrated Medical Systems to Steris, and Angiotech’s Interventional business to Argon Medical Devices (then owned by RoundTable Healthcare Partners).  Notable restructuring experience includes creditor representations with respect to Ameritox and Angiotech Pharmaceuticals.

Prior Experience

Previously, Mr. Soden was a Managing Director & Head of Medical Technologies at Houlihan Lokey for nearly seven years.  Before Houlihan Lokey, Mr. Soden worked for six years in the Healthcare Group at Thomas Weisel Partners, most recently as a Managing Director, and for five years at UBS, serving as a Director in both the M&A and Healthcare groups. He began his investment banking career as a financial analyst at CS First Boston in 1994.


Mr. Soden received a B.S. in Economics (with Honors) from Northwestern University.